Chronic kidney disease trials in India

In India 19 Also abroad 798

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
Where
New Delhi
Age
18 years and over
People
90
Run by
Institute of Liver and Biliary Sciences, India
See details and how to joinNCT07391267
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Bangalore, Belagavi, Hyderabad, Kolkata, Madurai, Mumbai, New Delhi, Pune, Vijayawada
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Guntur, Hubli, Hyderabad, Kanpur, Kolkata, Kozhikode, Lucknow, Nagpur, New Delhi, Patna, Raipur, Vadodara
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Bengaluru, Chennai, Lucknow, Vellore
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Bangalore, Hyderabad, New Delhi
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Where
Ahmedabad, Chennai, Dehradun, Ghaziabad, Hyderabad, Indore, Kolkata, Lucknow, Mangaluru, Meppādi, Patna, Puducherry, Raipur, Siliguri, Vadodara, Visakhapatnam
Age
18 years and over
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06058585 · EU 2024-520253-21-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Ahmedabad, Bengaluru, Delhi, Kolkata
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Aligarh, Belagavi, Bhubaneswar, Calicut, Coimbatore, Dehli, Dehradun, Hyderabad, Jaipur, Jodhpur, Kanpur, Kochi, Kolkata, Mumbai, Mysore, Nagpur, New Delhi, Pune, Thiruvananthapuram, Vijayawada
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Ahmedabad, Kolkata, Mumbai
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Aligarh, Bangalore, Belagavi, Bhubaneswar, Calicut, Chennai, Dehradun, Delhi, Gūrgaon, Guwahati, Haryāna, Hyderabad, Kolkata, Kottayam, Mumbai, Mysuru, New Delhi, Noida, Secunderabad, Varanasi
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Aligarh, Belagavi, Belgavi, Calicut, Chennai, Coimbatore, Delhi, Guntur, Kolkata, Lucknow, Nagpur, Pune
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
No phaseNot yet taking people in India
Effectiveness of Subgingival Instrumentation on Delaying End-stage Renal Disease Among Chronic Kidney Disease Patients
Where
Rohtak
Age
40 years to 70 years
People
40
Run by
Postgraduate Institute of Dental Sciences Rohtak
See details and how to joinNCT07635797
No phaseNot yet taking people in India
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.
Where
New Delhi
Age
18 years to 80 years
People
160
Run by
Institute of Liver and Biliary Sciences, India
See details and how to joinNCT07585526
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Bengaluru, Guntur, Hyderabad, Jaipur, Kozhikode
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
Phase 3Taking people
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Where
Bangalore, Belagavi, Kolkata, New Delhi
Age
0 years to 18 years
People
56 worldwide
Run by
Amgen
See details and how to joinNCT03633708
Phase 4Taking people
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
Where
Bhubaneswar, Chennai, Delhi, Hyderabad, Lucknow, Mumbai, Mysuru, Nadiād, Puducherry, Udupi, Vellore
Age
18 years to 65 years
People
585
Run by
Christian Medical College, Vellore, India
See details and how to joinNCT06676384
Phase 4Taking people
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Where
Ambāla, Balasore, Bengaluru, Bhetia, Bhubaneswar, Bokāro, Borivali West, Chennai, Chīrāla, Coimbatore, Dhanbad, Gūdūr, Guntur, Hindupur PPP, Hubli, Hyderabad, Indore, Kākināda, Kanigiri, Kanpur, Khammam, Kilpauk, Kolathūr, Kolkata, Kothagudem, Kurnool, Lucknow, Ludhiana, Machilipatnam, Mārkāpur, Mumbai, Nalgonda, Nandyāl, Narsīpatnam, Neyveli, Noida, Old Palasia, Palakonda, Srikakulam District, Palāsa, Pārvathipuram, Patna, Proddatūr, Pune, Rajahmundry, Ranchi, Secunderabad, Sompeta, Srikakulam, Tadepalligudem, Tamlūk, Thane, Tirupati, Uttar Mechgram, Vijayawada, Visakhapatnam
Age
18 years and over
People
50,000 worldwide
Run by
University of Sydney
See details and how to joinNCT02823821
No phaseTaking people
Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD
Where
Hyderabad
Age
18 years to 75 years
People
74
Run by
Asian Institute of Gastroenterology, India
See details and how to joinNCT06874036
Phase 4Taking people
A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
Where
Sheikhpura
Age
18 years to 85 years
People
1,004
Run by
Zydus Lifesciences Limited
See details and how to joinNCT05515367